Cargando…
Effects of N-acetylcysteine on systemic lupus erythematosus disease activity and its associated complications: a randomized double-blind clinical trial study
BACKGROUNDS: N-acetylcysteine (NAC) has broadly been used as an anti-oxidant agent in various types of diseases. This study aimed to assess the effect of NAC on the systemic lupus erythematosus (SLE) disease activity and outcome. METHODS: In this randomized, double-blind clinical trial study, 80 SLE...
Autores principales: | Abbasifard, Mitra, Khorramdelazad, Hossein, Rostamian, Abdolrahman, Rezaian, Mohsen, Askari, Pooya Saeed, Sharifi, Gholamhosein Taghipur Khajeh, Parizi, Moein Kardoust, Sharifi, Mobina Taghipour Khajeh, Najafizadeh, Seyed Reza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9945717/ https://www.ncbi.nlm.nih.gov/pubmed/36810107 http://dx.doi.org/10.1186/s13063-023-07083-9 |
Ejemplares similares
-
Assessing the expression of immunosuppressive cytokines in the newly diagnosed systemic lupus Erythematosus patients: a focus on B cells
por: Abbasifard, Mitra, et al.
Publicado: (2020) -
The bio-mission of interleukin-6 in the pathogenesis of COVID-19: A brief look at potential therapeutic tactics
por: Abbasifard, Mitra, et al.
Publicado: (2020) -
Effective Treatments for Bladder Cancer Affecting CXCL9/CXCL10/CXCL11/CXCR3 Axis: A Review
por: Nazari, Alireza, et al.
Publicado: (2020) -
Prevalence and complication of COVID‐19 in patients with ankylosing spondylitis (AS) and its relationship with TNF‐a inhibitors
por: Movassaghi, Shafieh, et al.
Publicado: (2023) -
Improvement in endothelial dysfunction in patients with systemic lupus erythematosus with N-acetylcysteine and atorvastatin
por: Kudaravalli, Jyothsna
Publicado: (2011)